{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T20:41:14Z","timestamp":1795034474373,"version":"4.10.2"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.lanepe.2024.100967","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T21:19:02Z","timestamp":1718227142000},"page":"100967","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"special_numbering":"C","title":["Comparing CHA2DS2-VA and CHA2DS2-VASc scores for stroke risk stratification in patients with atrial fibrillation: a temporal trends analysis from the retrospective Finnish AntiCoagulation in Atrial Fibrillation (FinACAF) cohort"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4460-0994","authenticated-orcid":false,"given":"Konsta","family":"Teppo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Yoke Hong","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari Eino Juhani","family":"Airaksinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli","family":"Halminen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1450-6208","authenticated-orcid":false,"given":"Jari","family":"Haukka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka","family":"Putaala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1472-0946","authenticated-orcid":false,"given":"Pirjo","family":"Mustonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miika","family":"Linna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0847-107X","authenticated-orcid":false,"given":"Juha","family":"Hartikainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Lehto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanepe.2024.100967_bib1","article-title":"Atrial fibrillation: epidemiology, screening and digital health","volume":"37","author":"Linz","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.lanepe.2024.100967_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/ehjqcco\/qcaa093","article-title":"Atrial fibrillation in the UK: predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs","volume":"8","author":"Burdett","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.lanepe.2024.100967_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/qjmed\/hcu054","article-title":"Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis","volume":"107","author":"Wagstaff","year":"2014","journal-title":"QJM"},{"key":"10.1016\/j.lanepe.2024.100967_bib4","article-title":"Sex as a risk factor for atrial fibrillation-related stroke","author":"Corica","year":"2023","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lanepe.2024.100967_bib5","doi-asserted-by":"crossref","DOI":"10.1007\/s11739-019-02134-z","article-title":"Sex-related differences in prevalence, treatment and outcomes in patients with atrial fibrillation","volume":"15","author":"Marzona","year":"2020","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.lanepe.2024.100967_bib6","doi-asserted-by":"crossref","DOI":"10.1177\/1060028020904969","article-title":"The tasmanian atrial fibrillation study (TAFS): differences in stroke prevention according to sex","volume":"54","author":"Pilcher","year":"2020","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.lanepe.2024.100967_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14107","article-title":"Temporal trends of gender disparities in oral anticoagulant use in patients with atrial fibrillation","volume":"54","author":"Teppo","year":"2024","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.lanepe.2024.100967_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/STROKEAHA.116.015900","article-title":"Do women with atrial fibrillation experience more severe strokes?: results from the Austrian stroke unit registry","volume":"48","author":"Lang","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.lanepe.2024.100967_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/bmj.312.7022.45","article-title":"ABC of atrial fibrillation: antithrombotic treatment for atrial fibrillation","volume":"312","author":"Lip","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.lanepe.2024.100967_bib10","doi-asserted-by":"crossref","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.lanepe.2024.100967_bib11","article-title":"The value of the CHA 2DS 2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS 2 score 0-1: a nationwide cohort study","volume":"107","author":"Olesen","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lanepe.2024.100967_bib12","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lanepe.2024.100967_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.117.029081","article-title":"Female sex is a risk modifer rather than a risk factor for stroke in atrial fibrillation should we use a CHA 2 DS 2 -VA score rather than CHA 2 DS 2 -VASc?","volume":"137","author":"Nielsen","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.lanepe.2024.100967_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae198","article-title":"Ischaemic stroke in women with atrial fibrillation: temporal trends and clinical implications","volume":"45","author":"Teppo","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lanepe.2024.100967_bib15","article-title":"Trends in treatment and outcomes of atrial fibrillation during 2007\u201317 in Finland","volume":"9","author":"Teppo","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.lanepe.2024.100967_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10654-021-00812-x","article-title":"The nationwide Finnish anticoagulation in atrial fibrillation (FinACAF): study rationale, design, and patient characteristics","volume":"37","author":"Lehto","year":"2022","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.lanepe.2024.100967_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0276612","article-title":"Rural-urban differences in the initiation of oral anticoagulant therapy in patients with incident atrial fibrillation: a Finnish nationwide cohort study","volume":"17","author":"Teppo","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.lanepe.2024.100967_bib18","article-title":"Socioeconomic disparities in use of rhythm control therapies in patients with incident atrial fibrillation: a Finnish nationwide cohort study","volume":"41","author":"Teppo","year":"2022","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.lanepe.2024.100967_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/srep27410","article-title":"Stroke and thromboembolic event rates in atrial fibrillation according to different guideline treatment thresholds: a nationwide cohort study","volume":"6","author":"Nielsen","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.lanepe.2024.100967_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/ehjcvp\/pvw022","article-title":"Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA2DS2-VASc score","volume":"3","author":"Overvad","year":"2017","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.lanepe.2024.100967_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.cjca.2019.01.018","article-title":"Importance of risk reassessment in patients with atrial fibrillation in guidelines: assessing risk as a dynamic process","volume":"35","author":"Chang","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.lanepe.2024.100967_bib22","article-title":"Dynamic assessment of CHA2DS2-VASc and HAS-BLED scores for predicting ischemic stroke and major bleeding in atrial fibrillation patients","author":"Serna","year":"2024","journal-title":"Rev Espa\u00f1ola Cardiol"},{"key":"10.1016\/j.lanepe.2024.100967_bib23","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"0","author":"Joglar","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.lanepe.2024.100967_bib24","article-title":"2021 focused update consensus guidelines of the Asia Pacific heart rhythm society on stroke prevention in atrial fibrillation: executive summary","volume":"122","author":"Chao","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lanepe.2024.100967_bib25","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart disease and stroke statistics - 2018 update: a report from the American Heart Association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.lanepe.2024.100967_bib26","doi-asserted-by":"crossref","DOI":"10.1186\/s41512-018-0037-2","article-title":"Quantifying the added value of new biomarkers: how and how not","volume":"2","author":"Cook","year":"2018","journal-title":"Diagn Progn Res"},{"key":"10.1016\/j.lanepe.2024.100967_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/biomet\/89.3.635","article-title":"Comparing nonnested Cox models","volume":"89","author":"Fine","year":"2002","journal-title":"Biometrika"},{"key":"10.1016\/j.lanepe.2024.100967_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/sim.4085","article-title":"Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers","volume":"30","author":"Pencina","year":"2011","journal-title":"Stat Med"},{"key":"10.1016\/j.lanepe.2024.100967_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/aje\/kwr086","article-title":"Evaluating the incremental value of new biomarkers with integrated discrimination improvement","volume":"174","author":"Kerr","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.lanepe.2024.100967_bib30","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6947-8-53","article-title":"Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers","volume":"8","author":"Vickers","year":"2008","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.lanepe.2024.100967_bib31","article-title":"A\u00a0new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score","volume":"2","author":"Singer","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.lanepe.2024.100967_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehw077","article-title":"Comparison of the ATRIA, CHADS2, and CHA2DS2-VASc stroke risk scores in predicting ischaemic stroke in a large Swedish cohort of patients with atrial fibrillation","volume":"37","author":"Aspberg","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lanepe.2024.100967_bib33","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.123.010269","article-title":"Estimating vitamin K antagonist anticoagulation benefit in people with atrial fibrillation accounting for competing risks: evidence from 12 randomized trials","volume":"17","author":"Shah","year":"2024","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.lanepe.2024.100967_bib34","article-title":"Independent predictors of stroke in patients with atrial fibrillation: a systematic review","volume":"69","author":"Hart","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.lanepe.2024.100967_bib35","article-title":"Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies","volume":"352","author":"Emdin","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.lanepe.2024.100967_bib36","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2016.0529","article-title":"Differences in clinical and functional outcomes of atrial fibrillation in women and men: two-year results from the ORBIT-AF Registry","volume":"1","author":"Piccini","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.lanepe.2024.100967_bib37","article-title":"Time trends in atrial fibrillation-related stroke during 2001\u20132020 in Sweden: a nationwide, observational study","volume":"28","author":"Ding","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.lanepe.2024.100967_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(21)00252-0","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"20","author":"Feigin","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.lanepe.2024.100967_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/sim.9717","article-title":"Pitfalls of the concordance index for survival outcomes","volume":"42","author":"Hartman","year":"2023","journal-title":"Stat Med"},{"key":"10.1016\/j.lanepe.2024.100967_bib40","doi-asserted-by":"crossref","DOI":"10.1093\/eurjpc\/zwae103","article-title":"Temporal trends in hypertension-related ischaemic stroke risk in atrial fibrillation from 2007 to 2018: a nationwide cohort study","author":"Teppo","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.lanepe.2024.100967_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110875","article-title":"Trends and burden of diabetes in patients with atrial fibrillation during 2007\u20132018: a Finnish nationwide cohort study","volume":"203","author":"Teppo","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.lanepe.2024.100967_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.hlc.2020.11.012","article-title":"Risk of stroke in atrial fibrillation according to sex in patients aged younger than 75 Years: a large-scale, observational study using real-world data","volume":"30","author":"Maeda","year":"2021","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.lanepe.2024.100967_bib43","doi-asserted-by":"crossref","DOI":"10.1253\/circj.CJ-15-0095","article-title":"Validation of risk scoring system excluding female sex from CHA2DS2-VASc in Japanese patients with nonvalvular atrial fibrillation:Subanalysis of the J-RHYTHM registry","volume":"79","author":"Tomita","year":"2015","journal-title":"Circ J"},{"key":"10.1016\/j.lanepe.2024.100967_bib44","article-title":"RETRACTED: choivalidation of the cha2ds2-VA score (excluding female sex) in nonvalvular atrial fibrillation patients: a nationwide population-based study. J Clin Med 2022, 11, 1823","volume":"12","author":"Choi","year":"2023","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.lanepe.2024.100967_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.hlc.2018.06.1043","article-title":"National heart foundation of Australia and the cardiac society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018","volume":"27","author":"Brieger","year":"2018","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.lanepe.2024.100967_bib46","article-title":"The validation of the Finnish hospital discharge register and causes of death register data on stroke diagnoses","volume":"14","author":"Tolonen","year":"2007","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.lanepe.2024.100967_bib47","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d124","article-title":"Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study","volume":"342","author":"Olesen","year":"2011","journal-title":"BMJ"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776224001340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776224001340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T05:26:15Z","timestamp":1722489975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666776224001340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":47,"alternative-id":["S2666776224001340"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2024.100967","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing CHA2DS2-VA and CHA2DS2-VASc scores for stroke risk stratification in patients with atrial fibrillation: a temporal trends analysis from the retrospective Finnish AntiCoagulation in Atrial Fibrillation (FinACAF) cohort","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2024.100967","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2024.100999","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100967"}}